Scientists at St. Jude Children's Research Hospital have revealed how Fanzor2's divergence from bacterial ancestors may make ...

Scientists have revealed how Fanzor2's divergence from bacterial ancestors may make it a useful tool for future genomic engineering endeavors.

October 1, 2024) A revolution in biomedicine is currently underway, driven by the application of genome engineering tools such as ...

A revolution in biomedicine is currently underway, driven by the application of genome engineering tools such as the ...

But as it turns out, CRISPR/Cas9 gene editing is a completely natural ... Now, two women have won the 2020 Nobel Prize in Chemistry “for developing a method for genome editing”.

Against the backdrop of a Cas9 patent battle that refuses to die, Editas Medicine is cashing in a chunk of the licensing ...

This year's Nobel Prize in physiology or medicine was awarded to United States scientists Victor Ambros and Gary Ruvkun "for ...

ERS Genomics, Université de Montréal ink CRISPR/Cas9 license agreement: Dublin, Ireland Thursday, October 3, 2024, 09:00 Hrs [IST] ERS Genomics Limited (ERS), the CRISPR licensi ...

Amidst the long-running Cas9 patent battle, Editas Medicine has struck a deal to sell a portion of its future revenue stream ...

Drs Emmanuelle Charpentier and Jennifer Doudna have won this year’s Nobel Prize for chemistry in recognition of their work on the gene-editing technology CRISPR/Cas9. Charpentier – currently ...